NCT03768180 (INTENSE) is a clinical trial in Infective Endocarditis of Aortic Valve, sponsored by Region Skane.

Who is sponsoring NCT03768180?

NCT03768180 is sponsored by Region Skane.

What condition does NCT03768180 study?

NCT03768180 studies Infective Endocarditis of Aortic Valve.

Is NCT03768180 still recruiting?

NCT03768180 is currently completed. Last updated 6 April 2020.

Last reviewed 2020-04-06 · How we verify

NCT03768180: INTENSE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Infective Endocarditis After TAVR

Completed Last updated 6 April 2020

What this trial tests

trial in Infective Endocarditis of Aortic Valve in 4,600 participants. Completed in 1 August 2019.

Timeline

1 January 2018

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	Region Skane
Status	Completed
Study type	OBSERVATIONAL
Enrollment	4,600
Start date	1 January 2018
Primary completion	1 August 2019
Estimated completion	1 August 2019
Sites	1 location across Sweden

Conditions studied

Infective Endocarditis of Aortic Valve — all drugs for Infective Endocarditis of Aortic Valve →

Sponsor

Region Skane — full company profile →

Who can join

Eligibility, any sex, with Infective Endocarditis of Aortic Valve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims at studying the frequency of infective endocarditis after transcatheter aortic valve replacement/implantation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.
Bjursten H, Rasmussen M, Nozohoor S, Götberg M, et al · · 2019 · cited 85× · PMID 31433472 · DOI 10.1093/eurheartj/ehz588

Verify or expand the search:

Other Region Skane trials

Trials by the same sponsor.

NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
NCT07494669 — Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery · not yet recruiting
NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03768180 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region Skane
Last refreshed: 6 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03768180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing